PETMED EXPRESS INC — Form 8-K
Filed September 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
PetMed Express appointed Dr. Tamar Elkeles as an independent director and Chair of the Compensation and Human Capital Committee effective September 17, 2026. Dr. Elkeles brings 30+ years of experience, including 23 years as Chief Learning & Talent Officer at Qualcomm (1992–2015), where she supported growth from $100M to $25B+ in revenue. The appointment follows the company's recent CEO transition to Jeff Willard from interim CEO Leslie C.G. Campbell.
Why this rating
Board appointment is routine governance; no financial impact, equity issuance, or business terms disclosed. Relevant to culture/talent but immaterial relative to $46M market cap.
See more from September 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.